期刊文献+

阴沟肠杆菌产β-内酰胺酶的研究进展 被引量:7

The advance of β-lactamases produced by Enterobacter cloacae
下载PDF
导出
摘要 阴沟肠杆菌产β-内酰胺酶是对β-内酰胺类抗生素耐药的主要机制,所产β-内酰胺酶种类较多、特性各异,并在β-内酰胺类抗生素广泛应用的选择压力下,不断有新的β-内酰胺酶产生。文中对阴沟肠杆菌产β-内酰胺酶(EsBLs、AmpC、碳青霉烯酶)耐药性的研究进展作了简要综述。 The most important mechanism of resistance to β-lactam antibiotics is the β-lactamases produced by Enterobacter cloacae, and theβ-lactamases is different in catology and character and produce a new ones under Enterobacter cloacae that contain β-1actamases encounter simultaneous or consecutive selective pressure with different β-lactamases molecules. This review describes evolution and characteristics of the β-lactamases produce by Enterobacter cloacae.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2011年第12期881-884,905,共5页 Chinese Journal of Antibiotics
关键词 Β-内酰胺酶 阴沟肠杆菌 耐药性 β-lactamase Enterobacter cloacae Drug resistance
  • 相关文献

参考文献25

二级参考文献111

共引文献912

同被引文献46

  • 1周洁,郭晓云,莫曾南,黄伟华,李萌.上尿路结石术后阴沟肠杆菌感染临床特点分析及意义[J].中国综合临床,2007,23(10):940-942. 被引量:6
  • 2丁娟娟,吕晓菊,宗志勇,等.52例阴沟肠杆菌败血症的临床分析[A].第六届全国抗菌药物临床药理学术会议论文集[C].2006.
  • 3Paterson DL, KOWC, Von Gottberg A, et al . outcome of ceph- alosporin treatment for serious infections due to apparently sus ceptible organisms producing extended - spectrum β-1actamas- es: implications for the clinical microbiology laboratory[J]. J clin Microbiol,2001,39:2203.
  • 4AndersonK F, LonswayD R, Rasheed K, et al. Evaluation of methods to identify the Klebesilla pneumoniae carbapenemase in Enterobacteriaceae[J]. Clin Microbiol, 2007,45 (8) : 2723- 2725.
  • 5Jeong SH, Lee K, Chong Y, et al. Characterization of a new integron containing VIM-2, a metallo-beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae [J]. Antimicrob Chemother, 2003, 51 (2): 397-400.
  • 6Housby JN, Mann NH. Phage therapy[J]. Drug Discovery Today, 2009, 14 (11): 536-540.
  • 7Matushima A, Takakura S, Fujihara N, et al. High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection [J]. Clin Microbiol Infec, 2010, 16 (9): 1488-1493.
  • 8Panopoulou M, Alepopoulou E, Ikonomidis A, et al. Emergence of VIM-12 in Enterobacter cloacae [J]. J Clin Microbiol, 2010, 48 (9): 3414-3415.
  • 9Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial infections [J]. Int J Antimicrobial Agents, 2007, 30 (2): 118-128.
  • 10Fu W, Forater T, Mayer O, et al. Bacteriophage cocktail for the prevention of biofilm formation by Psedomonas aeruginosa on catheters in an in vivo model system [J]. Antimcrob AgentsChemother, 2010, 54 (1): 397-404.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部